Activating mutations in CD79B, CARD11 and MYD88 and inactivation mutations in TNFAIP3, leading to activation of NFkB pathway, constitute the hallmark of ABC-like DLBCL as has been reported in multiple publications [34, 35, 40]. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.